• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疑似胰高血糖素瘤患者血浆胰高血糖素免疫反应性的分布

Distribution of plasma glucagon immunoreactivity in a patient with suspected glucagonoma.

作者信息

Valverde I, Lemon H M, Kessinger A, Unger R H

出版信息

J Clin Endocrinol Metab. 1976 May;42(5):804-8. doi: 10.1210/jcem-42-5-804.

DOI:10.1210/jcem-42-5-804
PMID:178682
Abstract

Gel filtration of plasma from a patient with a clinical syndrome of glucagonoma and a total plasma glucagon level of 2600 pg/ml, revealed the four glucagon immunoreactive fractions found in normal subjects. The total hyperglucagonemia observed was due to high levels of true glucagon and proglucagon moieties. The so-called "big plasma glucagon" (BPG) measured 190 pg/ml (normal average 113 +/- 79 pg/ml, Mean +/- SD, N = 10); the large glucagon immunoreactivity, LGI (9000 mol wt), measured 625 pg/ml (normal average 11 +/- 16 pg/ml); the true glucagon accounted for 1435 pg/ml (normal average 31 +/- 29 pg/ml); and the small glucagon immunoreactive fraction (approximately 2000 mol wt) measured 35 pg/ml (normal average 26 +/- 18 pg/ml). The high levels of LGI, considered a candidate for proglucagon, may reflect the increased secretory activity of the tumor.

摘要

对一名患有胰高血糖素瘤临床综合征且血浆胰高血糖素总水平为2600 pg/ml的患者的血浆进行凝胶过滤,发现了正常受试者体内存在的四种胰高血糖素免疫反应性组分。观察到的总高胰高血糖素血症是由于真实胰高血糖素和胰高血糖素原部分的高水平所致。所谓的“大血浆胰高血糖素”(BPG)为190 pg/ml(正常平均值为113±79 pg/ml,均值±标准差,N = 10);大胰高血糖素免疫反应性物质,LGI(9000分子量)为625 pg/ml(正常平均值为11±16 pg/ml);真实胰高血糖素占1435 pg/ml(正常平均值为31±29 pg/ml);小胰高血糖素免疫反应性组分(约2000分子量)为35 pg/ml(正常平均值为26±18 pg/ml)。被认为是胰高血糖素原候选物的LGI的高水平可能反映了肿瘤分泌活性的增加。

相似文献

1
Distribution of plasma glucagon immunoreactivity in a patient with suspected glucagonoma.疑似胰高血糖素瘤患者血浆胰高血糖素免疫反应性的分布
J Clin Endocrinol Metab. 1976 May;42(5):804-8. doi: 10.1210/jcem-42-5-804.
2
Elevated plasma proglucagon-like component with a glucagon-secreting tumor. Effect of streptozotocin.胰高血糖素分泌瘤患者血浆中胰高血糖素原类似成分升高。链脲佐菌素的作用。
N Engl J Med. 1976 Jul 29;295(5):242-5. doi: 10.1056/NEJM197607292950502.
3
Secretory response and immunochemical heterogeneity of glucagon in plasma and tumor extracts of a patient with glucagonoma.一位胰高血糖素瘤患者血浆及肿瘤提取物中胰高血糖素的分泌反应和免疫化学异质性
Horm Res. 1986;23(3):159-66. doi: 10.1159/000180312.
4
Familial hyperglucagonemia--an autosomal dominant disorder.家族性高胰高血糖素血症——一种常染色体显性疾病。
N Engl J Med. 1977 Mar 10;296(10):534-8. doi: 10.1056/NEJM197703102961003.
5
Heterogeneity of plasma glucagon. Circulating components in normal subjects and patients with chronic renal failure.血浆胰高血糖素的异质性。正常受试者和慢性肾衰竭患者的循环成分。
J Clin Invest. 1976 Sep;58(3):742-50. doi: 10.1172/JCI108521.
6
Plasma immunoreactive glucagon fractions in four cases of glucagonoma: increased "large glucagon-immunoreactivity".四例胰高血糖素瘤患者的血浆免疫反应性胰高血糖素组分:“大胰高血糖素免疫反应性”增加。
Diabetologia. 1976 Aug;12(4):319-26. doi: 10.1007/BF00420975.
7
Immunologic characterization of plasma glucagon components in a patient with malignant glucagonoma.
Metabolism. 1984 Aug;33(8):728-33. doi: 10.1016/0026-0495(84)90213-0.
8
The glucagonoma syndrome: stimulus-induced plasma responses of circulating glucagon components IRG9000 and IRG3500.胰高血糖素瘤综合征:刺激诱导的循环胰高血糖素成分IRG9000和IRG3500的血浆反应。
Acta Endocrinol (Copenh). 1984 Feb;105(2):226-32. doi: 10.1530/acta.0.1050226.
9
Effect of somatostatin in the Syrian hamster bearing a transplantable islet-cell tumor.生长抑素对携带可移植胰岛细胞瘤的叙利亚仓鼠的影响。
Horm Metab Res. 1978 Mar;10(2):105-10. doi: 10.1055/s-0028-1093453.
10
Differences in molecular heterogeneity of glucagon-like immunoreactivity in plasma and liver metastases of a patient with alpha-cell tumor.一名α细胞瘤患者血浆和肝转移灶中胰高血糖素样免疫反应性的分子异质性差异。
Exp Clin Endocrinol. 1985 Feb;85(1):89-94. doi: 10.1055/s-0029-1210424.

引用本文的文献

1
The long-acting somatostatin analogue octreotide alleviates symptoms by reducing posttranslational conversion of prepro-glucagon to glucagon in a patient with malignant glucagonoma, but does not prevent tumor growth.长效生长抑素类似物奥曲肽可通过减少一名恶性胰高血糖素瘤患者中前胰高血糖素原向胰高血糖素的翻译后转化来缓解症状,但不能阻止肿瘤生长。
Clin Investig. 1994 Jan;72(2):127-33. doi: 10.1007/BF00184589.
2
Effect of streptozotocin in a case of glucagon-secreting malignant islets-cell tumor.链脲佐菌素对一例分泌胰高血糖素的恶性胰岛细胞瘤的作用。
J Endocrinol Invest. 1984 Apr;7(2):111-5. doi: 10.1007/BF03348399.
3
Molecular heterogeneity of glucagon in normal subjects and in patients with glucagon-producing tumours.
正常受试者及胰高血糖素瘤患者体内胰高血糖素的分子异质性。
Diabetologia. 1983 May;24(5):359-65.
4
Pancreatic glucagonoma with and without syndrome. Immunocytochemical study of 5 tumour cases and review of the literature.伴或不伴综合征的胰腺高血糖素瘤。5例肿瘤病例的免疫细胞化学研究及文献复习
Virchows Arch A Pathol Anat Histol. 1980;388(1):51-67. doi: 10.1007/BF00430676.
5
Secretion by glucagonomas of a possible glucagon precursor.胰高血糖素瘤分泌一种可能的胰高血糖素前体。
J Clin Invest. 1977 Feb;59(2):325-30. doi: 10.1172/JCI108644.
6
Dominant inheritance of large molecular weight immunoreactive glucagon.大分子免疫反应性胰高血糖素的显性遗传
J Clin Invest. 1978 Mar;61(3):763-9. doi: 10.1172/JCI108990.